Production (Stage)
Lotus Pharmaceuticals, Inc.
LTUS
$0.005
-$0.0009-15.25%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | -81.29% | -71.94% | -54.65% | -231.19% | 24.28% |
| Total Depreciation and Amortization | -8.37% | -7.60% | -8.32% | 0.66% | 25.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | -174.47% | -100.00% | 909.39% | 169.14% | 163.88% |
| Change in Net Operating Assets | -16.15% | 371.32% | 66.52% | 492.52% | -5.73% |
| Cash from Operations | -61.09% | -53.43% | 57.01% | 27.62% | 12.96% |
| Capital Expenditure | 54.78% | 47.20% | 29.28% | -274.67% | -25.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 54.78% | 47.20% | 29.28% | -56.48% | -25.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -98.64% | 228.57% | 1,100.00% | 19,800.00% | 612.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -301.71% | -812.90% | 98.97% | -68.05% | -124.77% |